Alkaline mineral metal composition as well as preparation method and application thereof

By using the synergistic effect of the prepared alkaline mineral metal composition, the problem of insufficient broad-spectrum antiviral effect in the prior art is solved, effective inhibition of various viruses and improvement of host immunity is achieved, and A safe and effective anti-viral solution.

CN118903199APending Publication Date: 2024-11-08NORTHEAST AGRICULTURAL UNIVERSITY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410956062.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-16
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

The existing technology has insufficient broad-spectrum antiviral effects in preventing and treating viral infectious diseases in livestock. Common methods such as vaccines, antiviral drugs and Chinese herbal medicines have problems such as safety hazards, drug resistance and environmental impact, making it difficult to effectively deal with virus mutations and new Virus Challenge.

Method used

Provided is a basic mineral metal composition, including 60 to 70 parts of metal ion composite, 25 to 30 parts of mineral ion composite, 1 to 9.5 parts of alkaline rare earth soluble salt and 0.5 to 4 parts of composite gel, Prepared by ionization method, it is used as a replacement for antiviral vaccines, and has a broad-spectrum antiviral effect.

Benefits of technology

Through synergistic effects, the composition enhances the body's lipid metabolism regulation and toxin filtration ability, significantly inhibits virus replication and transmission, improves the host's antiviral and immune ability, and provides stable antiviral effects, including coronavirus and Circle Various viruses such as cyclovirus and rotavirus have excellent inhibitory effects.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118903199A_ABST
    Figure CN118903199A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of livestock breeding, in particular to an alkaline mineral metal composition and a preparation method and application thereof. The alkaline mineral metal composition comprises a metal ion compound, a mineral ion compound, alkaline rare earth soluble salt and composite gel as effective components, is prepared by compounding according to a certain mass ratio, and can be used as a feed additive to be added into drinking water or directly used for feeding. All the components in the alkaline mineral metal composition have a synergistic effect and can jointly inhibit replication and propagation of viruses including coronavirus, circovirus, rotavirus, arteritis virus and herpes virus in livestock bodies, so that the toxin filtering capacity of the bodies is improved, the antiviral and immunocompetence of host cells is enhanced, and the toxic and side effects of the bodies are reduced. Hosts are helped to resist damage of viruses to bodies, the virus infection condition of livestock is effectively improved, and the vaccine can be used as a safe and effective antiviral vaccine substitute.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of animal husbandry, and in particular to an alkaline mineral metal composition and a preparation method and application thereof. Background Art

[0002] In recent years, with the rapid development of animal husbandry, the supply of livestock products has increased significantly, driving economic growth and improving people's living standards. However, with the expansion of breeding scale and the increase in the degree of intensification, the threat of viral infectious diseases in livestock has become increasingly serious. These diseases not only seriously affect the health and production performance of livestock, but also bring huge economic losses to farmers and the entire industry.

[0003] At present, the main methods for preventing and controlling viral infectious diseases in livestock include immunization, the use of antiviral drugs and antiviral Chinese herbal medicines. As the most commonly used antiviral means, livestock vaccines also face many challenges. For example, many viruses have multiple serotypes and mutate rapidly, which often leads to the inability of existing vaccines to provide effective protection, resulting in immune failure; although some vaccines can provide good immune effects, there are potential safety hazards. Although antiviral drugs such as ribavirin, amantadine and ribavirin are effective, they are toxic to body cells. Long-term use will lead to drug resistance and affect clinical effects. They are currently banned in domestic animals. The use of antibiotics can also easily cause pathogens to develop drug resistance and remain in the body, affecting the immune system of humans and animals through the food chain, destroying the balance of intestinal microecology, and increasing the risk of cross-infection. As an emerging prevention and control method, antiviral Chinese herbal medicines have played a certain role in the treatment and prevention of viral infectious diseases in livestock. However, their use in feed and drinking water will cause residual odor, affecting the export of meat products and limiting their international application. In addition, the effective ingredients and mechanisms of action of Chinese herbal medicines have not been fully studied, and the concentration of their toxic active ingredients is difficult to control, resulting in unstable antiviral effects under different environmental conditions, affecting the reliability of the treatment effect.

[0004] In summary, although existing technologies and drugs have controlled and alleviated viral infections in livestock to a certain extent, there are still many deficiencies and limitations, and there is no ideal, broad-spectrum antiviral drug with strong effects. The healthy and long-term development of animal husbandry still urgently needs to develop a more effective prevention and control method to cope with the challenges of viral mutations and new viruses in livestock breeding, and to ensure the health of livestock and the safety of livestock products. Summary of the invention

[0005] In order to overcome the above problems of the prior art, the present invention aims to provide an alkaline mineral metal composition and its preparation method and application. The alkaline mineral metal composition of the present invention has a strong antiviral effect and a broad-spectrum antiviral effect, and can be used as an effective antiviral vaccine substitute.

[0006] The invention provides an alkaline mineral metal composition, comprising the following components in parts by weight: 60-70 parts of metal ion complex, 25-30 parts of mineral ion complex, 1-9.5 parts of alkaline rare earth soluble salt and 0.5-4 parts of composite gel.

[0007] Preferably, the metal ion complex comprises a sodium compound, a potassium compound, a zinc compound and an iron compound; the mass ratio of sodium ions, potassium ions, zinc ions and iron ions in the sodium compound, potassium compound, zinc compound and iron compound is (16.48-19.02): (41.21-43.18): (0.23-0.25): (2.06-7.93); the sodium compound comprises one or more of sodium chloride, sodium carbonate, sodium selenate and sodium metasilicate; the potassium compound comprises one or more of potassium chloride, potassium iodide and potassium carbonate; the zinc compound comprises zinc gluconate; the iron compound comprises one or more of ferrous sulfate, ferrous lactate and ferrous gluconate.

[0008] Preferably, the mineral ion complex includes selenium compounds, iodine compounds and silicon compounds; the mass ratio of selenium ions, iodine ions and silicon ions in the selenium compounds, iodine compounds and silicon compounds is (1.14-4.67): (18.66-25): (1.14-4.67); the selenium compound includes sodium selenate; the iodine compound includes potassium iodide; and the silicon compound includes sodium metasilicate.

[0009] Preferably, the alkaline rare earth soluble salt comprises digermanate and lanthanum carbonate; the mass ratio of the digermanate to lanthanum carbonate is (0.87-3.8): (0.13-5.7).

[0010] Preferably, the composite gel comprises sodium alginate and nano-silver; the mass ratio of the sodium alginate to the nano-silver is (0.48-3): (0.02-1).

[0011] The present invention also provides a method for preparing the alkaline mineral metal composition described in the above technical solution, characterized in that it comprises the following steps:

[0012] The metal ion complex, the mineral ion complex and the alkaline rare earth soluble salt are sequentially dissolved in the composite gel and ionized to obtain an alkaline mineral metal composite.

[0013] Preferably, the ionization temperature is 25 to 35° C.; the ionization potential is -25 to 25 mV; and the ionization time is 1 to 2 days.

[0014] The present invention also provides an antiviral preparation, comprising the alkaline mineral metal composition described in the above technical scheme or the alkaline mineral metal composition prepared by the preparation method.

[0015] The present invention also provides the use of the alkaline mineral metal composition or the alkaline mineral metal composition or antiviral preparation prepared by the preparation method described in the above technical solution in the preparation of drugs for preventing and / or treating viral infections in livestock.

[0016] Preferably, the virus comprises one or more of a coronavirus, a circovirus, a rotavirus, an arterivirus and a herpes virus.

[0017] Beneficial effects:

[0018] The present invention provides an alkaline mineral metal composition and a preparation method and application thereof, wherein the alkaline mineral metal composition comprises the following raw materials in mass fractions: 60 to 70 parts of metal ion complexes, 25 to 30 parts of mineral ion complexes, 1 to 9.5 parts of alkaline rare earth soluble salts and 0.5 to 4 parts of composite gels. In the composition of the present invention, the metal ion complex can promote blood circulation, maintain homeostasis such as water balance and energy metabolism balance, improve the body's antioxidant effect, and promote the improvement of the immune system function, and the metal ion complex can regulate metabolism and body development, improve intestinal morphology, and help improve host immunity; the mineral ion complex can reduce the damage of free radicals to cells, improve immune system function, regulate host lipid metabolism, reduce cholesterol and promote bile acid synthesis, and inhibit pathogen transmission, and can also provide energy, effectively alleviating the problem of low immunity caused by insufficient nutrient intake; the alkaline rare earth soluble salt can promote blood circulation, reduce the levels of serum phosphate and calcium phosphate, and improve the body's toxin filtering ability; the composite gel itself can consolidate the intestinal barrier and help the host resist the damage caused by viruses to the body.

[0019] In the alkaline mineral metal composition of the present invention, there is a synergistic effect between each component, which greatly enhances the regulatory effect of body lipid metabolism. Since the virus completes multiple steps of its life cycle through complex interactions with host cell lipid metabolism, the alkaline mineral metal composition of the present invention inhibits virus replication and propagation by manipulating host lipid metabolism, and realizes directional antiviral treatment. At the same time, compounding between each component can synergistically improve the body's toxin filtering ability, and achieve the improvement of virus removal efficiency. In addition, the use of each component after combination can also further enhance the protective effect of the intestinal barrier, while reducing the damage of the virus to the body, the balance of immune function is regulated by the intestinal barrier, the antiviral and immune ability of the host cell are enhanced, and the invasion and infection of the virus are effectively inhibited. And as an alkaline mineral metal composition substrate, the composite gel can compound three kinds of complexes of metal ion complexes, mineral ion complexes, and alkaline rare earth soluble salts, and the product quality is stable, and a wide range of antiviral effects can be achieved to the maximum extent, including coronavirus, circovirus, rotavirus, arteritis virus and herpes virus. There is an excellent inhibitory effect, which can be used as an antiviral vaccine substitute for extensive antiviral. BRIEF DESCRIPTION OF THE DRAWINGS

[0020] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative labor.

[0021] Figure 1 This is a schematic diagram of the animal test process in Application Example 1;

[0022] Figure 2 This is a bar graph of the virus content in animal anal swabs in Application Example 1;

[0023] Figure 3 The results of transcriptomics and metabolomics analysis in Application Example 1 are shown in Figure 1, where A is the change in animal gene expression level, B is the enrichment result of differentially expressed genes, C is the change in animal metabolic expression level, and D is the classification result of differentially expressed metabolites;

[0024] Figure 4 This is a graph showing the test results of serum lipid-related biochemical indicators in Application Example 2;

[0025] Figure 5 The results of colon periodic acid Schiff staining and colon oil red staining in Application Example 2, wherein A is the colon periodic acid Schiff staining result, and B is the colon oil red staining result;

[0026] Figure 6The H&E staining and scanning electron microscope images of the colon in Application Example 3, where A is the H&E staining result and B is the scanning electron microscope image;

[0027] Figure 7 This is a schematic diagram of the cell test process in Application Example 4;

[0028] Figure 8 This is a result diagram of the virus replication rate in the cell culture supernatant in Application Example 4;

[0029] Fig. 9 This is the immunofluorescence image of intracellular virus infection in Application Example 4;

[0030] Fig.10 This is the fluorescence image of Nile red staining in cells in Application Example 5;

[0031] Fig.11 It is the bacterial density bar graph in Application Example 6;

[0032] Fig.12 This is a bar chart showing the antiviral effects of the alkaline mineral metal composition and its components in Application Example 7. DETAILED DESCRIPTION

[0033] The invention provides an alkaline mineral metal composition, comprising the following components in parts by weight: 60 to 70 parts of metal ion complex, 25 to 30 parts of mineral ion complex, 1 to 9.5 parts of alkaline rare earth soluble salt and 0.5 to 4 parts of composite gel.

[0034] In the present invention, the alkaline mineral metal composition is preferably composed of the following components by mass: 60-70 parts of metal ion complex, 25-30 parts of mineral ion complex, 1-9.5 parts of alkaline rare earth soluble salt and 0.5-4 parts of composite gel. In the composition of the present invention, the components work together to inhibit the replication and spread of viruses in livestock, improve the body's toxin filtering ability, enhance the host cell's antiviral and immune capabilities, and help the host resist the damage caused by the virus to the body.

[0035] In the present invention, the alkaline mineral metal composition includes 60 to 70 parts of metal ion complexes, preferably 65 parts, by weight. In the present invention, the metal ion complex can improve the body's antioxidant effect by improving blood circulation and maintaining homeostasis such as water balance and energy metabolism balance, and promote the improvement of immune system function. The metal ion complex can regulate metabolism and body development, improve intestinal morphology, and help improve host immunity.

[0036] In the present invention, the metal ion complex preferably includes a sodium compound, a potassium compound, a zinc compound and an iron compound. The mass ratio of sodium ion, potassium ion, zinc ion and iron ion in the sodium compound, potassium compound, zinc compound and iron compound is preferably (16.48-19.02): (41.21-43.18): (0.23-0.25): (2.06-7.93), and more preferably 17.27: 43.18: 0.23: 4.32.

[0037] In the present invention, the sodium compound preferably includes one or more of sodium chloride, sodium carbonate, sodium selenate and sodium metasilicate, more preferably sodium chloride, sodium selenate and sodium metasilicate. The present invention has no special requirements for the specific types of sodium compounds and the mass ratio of different types, only need to meet the final sodium ion content. The present invention has no special restrictions on the source of the specific types of sodium compounds, and the technical personnel in the field can purchase food grade conventionally. In the present invention, the potassium compound preferably includes one or more of potassium chloride, potassium iodide and potassium carbonate, more preferably potassium chloride and potassium iodide. The present invention has no special requirements for the specific types of potassium compounds and the mass ratio of different types, only need to meet the final potassium ion content. The present invention has no special restrictions on the source of the specific types of potassium compounds, and the technical personnel in the field can purchase food grade conventionally. In the present invention, the zinc compound preferably includes zinc gluconate. The present invention has no special requirements for the specific types of zinc compounds and the mass ratio of different types, only need to meet the final zinc ion content. The present invention has no special restrictions on the source of the specific types of zinc compounds, and the technical personnel in the field can purchase food grade conventionally. In the present invention, the iron compound preferably includes one or more of ferrous sulfate, ferrous lactate and ferrous gluconate, more preferably ferrous gluconate. The present invention has no special requirements on the specific type of iron compound and the mass ratio of different types, and only needs to meet the final iron ion content. The present invention has no special restrictions on the source of the specific type of iron compound, and the conventional food grade purchased by those skilled in the art can be used.

[0038] The present invention does not specifically limit the preparation process of the metal ion complex, and the components can be uniformly mixed. In the present invention, the metal ion complex contains a variety of ions, each of which has different properties, wherein sodium ions maintain fluid balance, potassium ions maintain the potential balance inside and outside the cell, and sodium ions and potassium ions are combined with water molecules to form hydrated ions, so that water can be retained and prevented from being lost, playing an important role in relieving dehydration of the body caused by diarrhea, and playing an important role in nerve conduction and muscle contraction, etc.; zinc ions are components of a variety of enzymes, participate in cell differentiation, immune function, growth and development, and DNA synthesis, and improve the body's immunity; iron ions participate in the synthesis of hemoglobin and the transportation of oxygen, and help maintain the body's homeostasis.

[0039] In the present invention, the alkaline mineral metal composition includes 25 to 30 parts of mineral ion complexes by weight, preferably 28 parts. In the present invention, the mineral ion complex can reduce the damage of free radicals to cells, improve the function of the immune system, regulate host lipid metabolism, reduce cholesterol and promote bile acid synthesis, inhibit the spread of pathogens, and provide energy, effectively alleviating the problem of low immunity caused by insufficient nutritional intake.

[0040] In the present invention, the mineral ion complex preferably includes selenium compounds, iodine compounds and silicon compounds, and the mass ratio of selenium ions, iodine ions and silicon ions in the selenium compounds, iodine compounds and silicon compounds is more preferably (1.14-4.67): (18.66-25): (1.14-4.67), and most preferably 4.67: 18.66: 4.67. In the present invention, the selenium compound preferably includes sodium selenate. The present invention has no special requirements for the specific types and mass ratios of different types of selenium compounds, and only needs to meet the final selenium ion content. The present invention has no special restrictions on the source of the specific types of selenium compounds, and the food grade can be purchased by technicians in the field. In the present invention, the iodine compound preferably includes potassium iodide. The present invention has no special requirements for the specific types and mass ratios of different types of iodine compounds, and only needs to meet the final iodine ion content. The present invention has no special restrictions on the source of the specific types of iodine compounds, and the food grade can be purchased by technicians in the field. In the present invention, the silicon compound preferably includes sodium metasilicate. The present invention has no special requirements on the specific types of silicon compounds and the mass ratio of different types, and only needs to meet the final silicon ion content. The present invention has no special restrictions on the source of the specific types of iodine compounds, and those skilled in the art can use conventional food grade ones.

[0041] The present invention does not specifically limit the preparation of the mineral ion complex, and the components can be uniformly mixed. In the present invention, the mineral ion complex contains a variety of ions, each of which has different properties: selenium ions have both growth-promoting and antioxidant effects, and play an important role in regulating intestinal metabolism and development and alleviating oxidative stress; iodine ions regulate the synthesis and metabolism of thyroid hormones, and maintain host nutrition by regulating endocrine-mediated lipid metabolism synthesis; silicon ions participate in the synthesis of collagen, maintain the health and strength of bones, and maintain the cell membrane barrier to resist virus invasion.

[0042] In the present invention, the alkaline mineral metal composition includes 1 to 9.5 parts of alkaline rare earth soluble salts, preferably 5 parts, by weight. In the present invention, the alkaline rare earth soluble salts can promote blood circulation, reduce the levels of serum phosphate and calcium phosphate, and improve the body's toxin filtering ability. In the present invention, the alkaline rare earth soluble salts preferably include digermanate and lanthanum carbonate, and the mass ratio of the digermanate and lanthanum carbonate is preferably (0.87 to 3.8): (0.13 to 5.7), more preferably 3.75: 1.25. The digermanate and lanthanum carbonate of the present invention are preferably present in the form of soluble salts. The present invention does not specifically limit the sources of the digermanate and lanthanum carbonate, and the conventional food grade purchased by those skilled in the art can be used. The present invention does not specifically limit the preparation of the alkaline rare earth soluble salts, and the components can be evenly mixed. In the present invention, lanthanum carbonate can reduce the levels of serum phosphate and calcium phosphate, regulate plasma proteins such as acidic glycoprotein, serum albumin and transferrin, and improve the body's toxin filtering ability; digermanate can promote blood circulation, reduce blood lipids, resist oxidation and enhance immunity.

[0043] In the present invention, the alkaline mineral metal composition includes 0.5 to 4 parts of the composite gel by weight, preferably 2 parts. In the present invention, the composite gel itself can strengthen the intestinal barrier and help the host resist the damage caused by viruses to the body.

[0044] In the present invention, the composite gel preferably includes sodium alginate and nanosilver, and the mass ratio of the sodium alginate to the nanosilver is preferably (0.48-3): (0.02-1), and more preferably 1.5:0.5. In the present invention, the nanosilver is preferably present in the form of nanoparticles. The present invention has no special limitation on the source of the nanosilver, and the nano-grade nanosilver conventionally purchased by a person skilled in the art can be used. The present invention has no special limitation on the source of the sodium alginate, and the food-grade nanosilver conventionally purchased by a person skilled in the art can be used.

[0045] In the present invention, the preparation method of the composite gel preferably includes the following steps: mixing the sodium alginate and nanosilver, performing a first dissolution to obtain a first dissolution product; mixing the first dissolution product with water, performing a second dissolution, stirring in the dark, and standing to obtain a composite gel. In the present invention, the mass volume ratio of the first dissolution product and water is (0.5-4) g:1L; the temperature of the first dissolution is preferably 25-35°C, more preferably 27°C; the time of the first dissolution is preferably standing for 1-2 days, more preferably 1 day; the temperature of the second dissolution is preferably 4-12°C, more preferably 4°C; the stirring time of the second dissolution is preferably 1-6 hours, more preferably 3 hours; the standing time is preferably 1-2 days, more preferably 1 day. In a specific embodiment of the present invention, the preparation method of the above-mentioned composite gel includes uniformly mixing sodium alginate and nanosilver, adding water to dissolve in the dark at 27°C for 1 day, stirring in the dark at 4°C for 3 hours, and standing for 1 day to prepare a composite gel. In another specific embodiment of the present invention, the method for preparing the above-mentioned composite gel comprises mixing sodium alginate and nano-silver uniformly, adding water to dissolve at 35°C in the dark for 2 days, stirring at 12°C in the dark for 6 hours, and standing for 1 day to prepare the composite gel. In another specific embodiment of the present invention, the method for preparing the above-mentioned composite gel comprises mixing sodium alginate and nano-silver uniformly, adding water to dissolve at 25°C in the dark for 1.5 days, stirring at 8°C in the dark for 1 hour, and standing for 1.5 days to prepare the composite gel. In the present invention, sodium alginate as a gelling agent has excellent moisturizing properties, can form an emulsion between water and oil, help mix and stabilize immiscible components, and improve the texture and stability of the product; nano-silver has excellent antibacterial properties and anti-inflammatory properties, can reduce inflammatory reactions, and promote wound healing.

[0046] The present invention also provides a method for preparing the alkaline mineral metal composition, comprising the following steps:

[0047] The metal ion complex, mineral ion complex and alkaline rare earth soluble salt are sequentially dissolved in a composite gel and ionized to obtain an alkaline mineral metal composition. In the present invention, the ionization temperature is preferably 25 to 35°C, more preferably 37°C; the ionization potential is preferably -25 to 25mV, and the ionization time is preferably 1 to 2d, more preferably 2d. In a specific embodiment of the present invention, the preparation method of the above-mentioned alkaline mineral metal composition comprises the following steps: the metal ion complex, mineral ion complex and alkaline rare earth soluble salt are sequentially dissolved in a composite gel and ionized, the ionization is carried out in a nitrogen environment, the ionization temperature is 27°C, the ionization potential is -25 to 25mV, and the ionization time is 2d. In another specific embodiment of the present invention, the preparation method of the above-mentioned alkaline mineral metal composition comprises the following steps: dissolving the metal ion complex, mineral ion complex and alkaline rare earth soluble salt in a composite gel in sequence, and ionizing, the ionization is carried out in a nitrogen environment, the ionization temperature is 25°C, the ionization potential is -25 to 25mV, and the ionization time is 1d. In another specific embodiment of the present invention, the preparation method of the above-mentioned alkaline mineral metal composition comprises the following steps: dissolving the metal ion complex, mineral ion complex and alkaline rare earth soluble salt in a composite gel in sequence, and ionizing, the ionization is carried out in a nitrogen environment, the ionization temperature is 30°C, the ionization potential is -25 to 25mV, and the ionization time is 1.5d. In the present invention, the step of dissolving the metal ion complex, mineral ion complex and alkaline rare earth soluble salt in a composite gel in sequence for ionization can cause specific ionization recombination between the components in the alkaline mineral metal composition, further enhancing the product stability of the alkaline mineral metal composition.

[0048] The present invention also provides an antiviral preparation, comprising the alkaline mineral metal composition described in the above technical solution or the alkaline mineral metal composition prepared by the preparation method. The virus preferably includes one or more of coronavirus, circovirus, rotavirus, arteritis virus and herpes virus. The coronavirus more preferably includes one or more of porcine epidemic diarrhea virus and porcine delta coronavirus. The circovirus more preferably includes porcine circovirus. The rotavirus more preferably includes porcine rotavirus; the arteritis virus more preferably includes porcine respiratory and reproductive disorder virus; the herpes virus more preferably includes porcine pseudorabies virus. The preparation preferably also includes pharmaceutically acceptable excipients. The present invention does not specifically limit the type and amount of the excipients of the preparation, and pharmaceutically acceptable excipients can be used. The present invention does not specifically limit the dosage form of the preparation, and pharmaceutically acceptable preparation dosage forms such as tablets, oral liquids, capsules, granules, powders, and pills can be used. In a specific embodiment of the present invention, the dosage form of the preparation is a liquid preparation, and the solvent of the preparation is preferably H2O. The method of using the liquid preparation includes: diluting the preparation with water, feeding the preparation to piglets after dilution 1000 times, and the feeding amount is 100mL / kg / d. In the present invention, the drug can be used according to the difference in the farmed animals, the difference in the age of the animals and the difference in the health status of the animals. In the present invention, the alkaline mineral metal composition can be used for symptomatic administration according to the actual pathological course of livestock, specifically according to the clinical experience of veterinarians, such as the degree of diarrhea, the water content of feces, color, whether livestock can walk normally, etc. The various components in the complex preparation of the present invention are used in combination, and the formula is scientific and reasonable, and can maximize the role of each component.

[0049] The present invention also provides the use of the alkaline mineral metal composition or the alkaline mineral metal composition or the antiviral preparation prepared by the alkaline mineral metal composition or the preparation method in the preparation of a drug for preventing and / or treating viral infection in livestock. In the present invention, the livestock preferably includes pigs, cattle or sheep, and the pigs more preferably include newborn piglets.

[0050] In the present invention, the application preferably includes the use of alkaline mineral metal compositions in the preparation of drugs for inhibiting virus replication and transmission, improving livestock toxin filtering capacity, enhancing livestock antiviral and immune capabilities, helping livestock resist damage to the body caused by viruses, or improving livestock viral infection conditions.

[0051] In the present invention, the virus preferably includes one or more of coronavirus, circovirus, rotavirus, arterivirus and herpesvirus.

[0052] In order to further illustrate the present invention, an alkaline mineral metal composition provided by the present invention and its preparation method and application are described in detail below in combination with the accompanying drawings and examples, but they should not be construed as limiting the scope of protection of the present invention.

[0053] Example 1 Preparation of Alkaline Mineral Metal Composition A

[0054] 1.1 Raw material preparation

[0055] 65g metal ion complex (containing sodium compounds with a total sodium ion content of 17.27g, potassium compounds with a total potassium ion content of 43.18g, zinc compounds with a total zinc ion content of 0.23g and iron compounds with a total iron ion content of 4.32g), 28g alkaline mineral complex (containing selenium compounds with a total selenium ion content of 4.67g, iodine compounds with a total iodine ion content of 18.66g and silicon compounds with a total silicon ion content of 4.67g), 5g alkaline rare earth soluble salt (3.75g digermanate and 1.25g lanthanum carbonate) and 2g composite gel (1.5g sodium alginate and 0.5g nanosilver).

[0056] In the metal ion complex, 17.27g sodium ions come from sodium compounds, including 17.62g sodium chloride, 11.18g sodium selenate and 20.29g sodium metasilicate; 43.18g potassium ions come from potassium compounds, including 71.38g potassium chloride and 24.41g potassium iodide; 0.23g zinc ions come from zinc compounds, including 1.6g zinc gluconate; 4.32g iron ions come from iron compounds, including 37.2g ferrous gluconate.

[0057] In the alkaline mineral complex, 18.66 g of iodine ions are derived from iodine compounds, including 24.41 g of potassium iodide; 4.67 g of selenium ions are derived from selenium compounds, including 11.18 g of sodium selenate; and 4.67 g of silicon ions are derived from silicon compounds, including 20.29 g of sodium metasilicate.

[0058] 1.2 Preparation of alkaline mineral metal compositions

[0059] 1) After 1.5g of sodium alginate and 0.5g of nanosilver are uniformly mixed, 1L of water is added and dissolved at 27°C in the dark for 1d, then stirred at 4°C in the dark for 3h, and allowed to stand for 1d to prepare a composite gel. 2) A sodium compound containing a total sodium ion content of 17.27g, a potassium compound containing a total potassium ion content of 43.18g, a zinc compound containing a total zinc ion content of 0.23g, and an iron compound containing a total iron ion content of 4.32g are uniformly mixed to prepare a metal ion complex. 3) A selenium compound containing a total selenium ion content of 4.67g, an iodine compound containing a total iodine ion content of 18.66g, and a silicon compound containing a total silicon ion content of 4.67g are uniformly mixed to prepare an alkaline mineral complex. 4) 3.75g of digermanate and 1.25g of lanthanum carbonate are uniformly mixed to prepare an alkaline rare earth soluble salt. 5) The metal ion complex obtained in step 2), the alkaline mineral complex obtained in step 3), and the alkaline rare earth soluble salt obtained in step 4) are sequentially added to the composite gel obtained in step 1), and after uniform mixing, ionization is performed in a nitrogen environment at 27°C with a potential of -25 to 25 mV. After 2 days, an alkaline mineral metal composite is obtained, which is stored at room temperature for later use.

[0060] Example 2 Preparation of basic mineral metal composition B

[0061] 1.1 Raw material preparation

[0062] 60g metal ion complex (containing sodium compounds with a total sodium ion content of 16.48g, potassium compounds with a total potassium ion content of 41.21g, zinc compounds with a total zinc ion content of 0.25g and iron compounds with a total iron ion content of 2.06g), 30g alkaline mineral complex (containing selenium compounds with a total selenium ion content of 2.5g, iodine compounds with a total iodine ion content of 25g and silicon compounds with a total silicon ion content of 2.5g), 9.5g alkaline rare earth soluble salt (3.8g digermanate and 5.7g lanthanum carbonate) and 0.5g composite gel (0.48g sodium alginate and 0.02g nanosilver).

[0063] In the metal ion complex, 16.48g of sodium ions come from sodium compounds, including 27.78g of sodium chloride, 5.98g of sodium selenate and 10.86g of sodium metasilicate; 41.21g of potassium ions come from potassium compounds, including 63.9g of potassium chloride and 32.7g of potassium iodide; 0.25g of zinc ions come from zinc compounds, including 1.74g of zinc gluconate; 2.06g of iron ions come from iron compounds, including 17.74g of ferrous gluconate.

[0064] In the alkaline mineral complex, 25 g of iodine ions come from iodine compounds, including 32.7 g of potassium iodide; 2.5 g of selenium ions come from selenium compounds, including 5.98 g of sodium selenate; and 2.5 g of silicon ions come from silicon compounds, including 10.86 g of sodium metasilicate.

[0065] 1.2 Preparation of alkaline mineral metal compositions

[0066] 1) After 0.48g of sodium alginate and 0.02g of nanosilver are uniformly mixed, 1L of water is added and dissolved at 35°C in the dark for 2d, then stirred at 12°C in the dark for 6h, and allowed to stand for 1d to prepare a composite gel. 2) A sodium compound containing a total sodium ion content of 16.48g, a potassium compound containing a total potassium ion content of 41.21g, a zinc compound containing a total zinc ion content of 0.25g, and an iron compound containing a total iron ion content of 2.06g are uniformly mixed to prepare a metal ion complex. 3) A selenium compound containing a total selenium ion content of 2.5g, an iodine compound containing a total iodine ion content of 25g, and a silicon compound containing a total silicon ion content of 2.5g are uniformly mixed to prepare an alkaline mineral complex. 4) 3.8g of digermanate and 5.7g of lanthanum carbonate are uniformly mixed to prepare an alkaline rare earth soluble salt. 5) The metal ion complex obtained in step 2), the alkaline mineral complex obtained in step 3), and the alkaline rare earth soluble salt obtained in step 4) are sequentially added to the composite gel obtained in step 1), and after uniform mixing, ionization is performed in a nitrogen environment at 25°C with a potential of -25 to 25 mV. After 1 day, an alkaline mineral metal composite is obtained and stored at room temperature for later use.

[0067] Example 3 Preparation of Alkaline Mineral Metal Composition C

[0068] 1.1 Raw material preparation

[0069] 70g metal ion complex (containing sodium compounds with a total sodium ion content of 19.02g, potassium compounds with a total potassium ion content of 42.81g, zinc compounds with a total zinc ion content of 0.24g and iron compounds with a total iron ion content of 7.93g), 25g alkaline mineral complex (containing selenium compounds with a total selenium ion content of 1.14g, iodine compounds with a total iodine ion content of 22.72g and silicon compounds with a total silicon ion content of 1.14g), 1g alkaline rare earth soluble salt (0.87g digermanate and 0.13g lanthanum carbonate) and 4g composite gel (3g sodium alginate and 1g nanosilver).

[0070] In the metal ion complex, 19.02g of sodium ions come from sodium compounds, including 41.94g of sodium chloride, 2.73g of sodium selenate and 4.95g of sodium metasilicate; 42.81g of potassium ions come from potassium compounds, including 68.29g of potassium chloride and 29.72g of potassium iodide; 0.24g of zinc ions come from zinc compounds, including 1.67g of zinc gluconate; 7.93g of iron ions come from iron compounds, including 68.28g of ferrous gluconate.

[0071] In the alkaline mineral complex, 22.72 g of iodine ions are derived from iodine compounds, including 29.72 g of potassium iodide; 1.14 g of selenium ions are derived from selenium compounds, including 2.73 g of sodium selenate; and 1.14 g of silicon ions are derived from silicon compounds, including 4.95 g of sodium metasilicate.

[0072] 1.2 Preparation of alkaline mineral metal compositions

[0073] 1) After 3g of sodium alginate and 1g of nanosilver are uniformly mixed, 1L of water is added and dissolved at 25°C in the dark for 1.5d, then stirred at 8°C in the dark for 1h, and allowed to stand for 1.5d to prepare a composite gel. 2) A sodium compound containing a total sodium ion content of 19.02g, a potassium compound containing a total potassium ion content of 42.81g, a zinc compound containing a total zinc ion content of 0.24g, and an iron compound containing a total iron ion content of 7.93g are uniformly mixed to prepare a metal ion complex. 3) A selenium compound containing a total selenium ion content of 1.14g, an iodine compound containing a total iodine ion content of 22.72g, and a silicon compound containing a total silicon ion content of 1.14g are uniformly mixed to prepare an alkaline mineral complex. 4) 0.87g of digermanate and 0.13g of lanthanum carbonate are uniformly mixed to prepare an alkaline rare earth soluble salt. 5) The metal ion complex obtained in step 2), the alkaline mineral complex obtained in step 3), and the alkaline rare earth soluble salt obtained in step 4) are sequentially added to the composite gel obtained in step 1), and after uniform mixing, ionization is performed in a nitrogen environment at 30°C with a potential of -25 to 25 mV. After 1.5 days, an alkaline mineral metal composite is obtained, which is stored at room temperature for later use.

[0074] Comparative Example 1 Preparation of Metal Ion Complex Single Component Material A1

[0075] 1.1 Raw material preparation

[0076] 100g of metal ion complex (containing a sodium compound with a total sodium ion content of 26.57g, a potassium compound with a total potassium ion content of 66.44g, a zinc compound with a total zinc ion content of 0.35g and an iron compound with a total iron ion content of 6.64g).

[0077] In the metal ion complex, 26.57g of sodium ions come from sodium compounds, including 67.54g of sodium chloride; 66.44g of potassium ions come from potassium compounds, including 126.69g of potassium chloride; 0.35g of zinc ions come from zinc compounds, including 2.44g of zinc gluconate; 6.64g of iron ions come from iron compounds, including 57.17g of ferrous gluconate.

[0078] 1.2 Preparation of single-component material A1

[0079] 1) A sodium compound containing a total sodium ion content of 26.57 g, a potassium compound containing a total potassium ion content of 66.44 g, a zinc compound containing a total zinc ion content of 0.35 g, and an iron compound containing a total iron ion content of 6.64 g are uniformly mixed to prepare a metal ion complex. 2) 1L of water is added to the metal ion complex obtained in step 1) and dissolved in the dark at 27°C for 1 day, then stirred in the dark at 4°C for 3 hours, and allowed to stand for 1 day to prepare a mixture. 3) The mixture is ionized in a nitrogen environment at 27°C with a potential of -25 to 25 mV. After 2 days, the metal ion complex single-component substance A1 is obtained and stored at room temperature for use.

[0080] Comparative Example 2 Preparation of Alkaline Mineral Complex Single Component Material A2

[0081] 1.1 Raw material preparation

[0082] 100 g of alkaline mineral complex (containing selenium compounds with a total selenium ion content of 16.67 g, iodine compounds with a total iodine ion content of 66.66 g, and silicon compounds with a total silicon ion content of 16.67 g).

[0083] In the alkaline mineral complex, 66.66 g of iodine ions are derived from iodine compounds, including 87.2 g of potassium iodide; 16.67 g of selenium ions are derived from selenium compounds, including 39.89 g of sodium selenate; and 16.67 g of silicon ions are derived from silicon compounds, including 72.44 g of sodium metasilicate.

[0084] 1.2 Preparation of single-component material A2

[0085] 1) A selenium compound containing a total selenium ion content of 16.67 g, an iodine compound containing a total iodine ion content of 66.66 g, and a silicon compound containing a total silicon ion content of 16.67 g are uniformly mixed to prepare an alkaline mineral complex. 2) 1L of water is added to the alkaline mineral complex obtained in step 1) and dissolved at 27°C in the dark for 1 day, then stirred at 4°C in the dark for 3 hours, and allowed to stand for 1 day to obtain a mixture. 3) The mixture is ionized in a nitrogen environment at 27°C with a potential of -25 to 25 mV. After 2 days, the alkaline mineral complex single-component substance A2 is obtained and stored at room temperature for use.

[0086] Comparative Example 3 Preparation of Alkaline Rare Earth Soluble Salt Single Component Material A3

[0087] 1.1 Raw material preparation

[0088] 100g alkaline rare earth soluble salt (containing 75g digermanate and 25g lanthanum carbonate).

[0089] 1.2 Preparation of single-component material A3

[0090] 1) Evenly mix 75g of digermanate and 25g of lanthanum carbonate to prepare an alkaline mineral complex. 2) Add 1L of water to the alkaline rare earth soluble salt obtained in step 1) and dissolve it at 27°C in the dark for 1 day, then stir at 4°C in the dark for 3 hours, and stand for 1 day to prepare a mixture. 3) The mixture is ionized in a nitrogen environment at 27°C with a potential of -25 to 25mV. After 2 days, the alkaline rare earth soluble salt single component substance A3 is obtained and stored at room temperature for use.

[0091] Comparative Example 4 Preparation of composite gel single component material A4

[0092] 1.1 Raw material preparation

[0093] 100g composite gel (60g sodium alginate and 40g nanosilver).

[0094] 1.2 Preparation of single-component material A4

[0095] 1) 60 g of sodium alginate and 40 g of nanosilver were uniformly mixed to prepare a composite gel. 2) 1 L of water was added to the composite gel obtained in step 1) and dissolved at 27°C in the dark for 1 day, then stirred at 4°C in the dark for 3 hours, and allowed to stand for 1 day to prepare a mixture. 3) The mixture was ionized in a nitrogen environment at 27°C with a potential of -25 to 25 mV. After 2 days, a composite gel single-component substance A4 was obtained and stored at room temperature for later use.

[0096] Comparative Example 5 Antiviral Composition Preparation D

[0097] 1.1 Raw material preparation

[0098] 25g metal ion complex (containing a sodium compound with a total sodium ion content of 17g, a potassium compound with a total potassium ion content of 7.3g, a zinc compound with a total zinc ion content of 0.05g, a germanium compound with a total germanium ion content of 0.05g, a titanium compound with a total titanium ion content of 0.2g, a magnesium compound with a total magnesium ion content of 0.1g and a manganese compound with a total manganese ion content of 0.3g), 68g composite reducing sugar preparation (9.3g reducing sugar, 49.4g rice bran and 9.3g brown sugar), 7g composite probiotics (the mass ratio of yeast, lactic acid bacteria, spore bacteria and photosynthetic bacteria is 1:2:1:0.4, the bacterial activity of yeast is 20 billion CFU / g, the bacterial activity of lactic acid bacteria is 3 billion CFU / g, the bacterial activity of spore bacteria is 10 billion CFU / g, and the bacterial activity of photosynthetic bacteria is 3 billion CFU / g)

[0099] In the metal ion complex, 17g sodium ions come from sodium compounds, including 62.08g sodium bicarbonate; 7.3g potassium ions come from potassium compounds, including 12.9g potassium carbonate; 0.05g zinc ions come from zinc compounds, including 0.35g zinc gluconate; 0.05g germanium ions come from germanium compounds, including 0.12g organic germanium; 0.2g titanium ions come from titanium compounds, including 0.33g titanium dioxide; 0.1g magnesium ions come from magnesium compounds, including 1.73g magnesium gluconate; 0.3g manganese ions come from manganese compounds, including 0.68g manganese chloride.

[0100] The reducing sugars in the composite reducing sugar preparation are glucose and fructose, and the mass ratio thereof is 1:1.

[0101] 1.2 Preparation of antiviral composition D

[0102] 1) A sodium compound with a total sodium ion content of 17g, a potassium compound with a total potassium ion content of 7.3g, a zinc compound with a total zinc ion content of 0.05g, a germanium compound with a total germanium ion content of 0.05g, a titanium compound with a total titanium ion content of 0.2g, a magnesium compound with a total magnesium ion content of 0.1g and a manganese compound with a total manganese ion content of 0.3g are uniformly mixed to prepare a metal ion complex. 2) 9.3g reducing sugar, 49.4g rice bran and 9.3g brown sugar are uniformly mixed to prepare a composite reducing sugar preparation. 3) The composite probiotics and the composite reducing sugar preparation are uniformly mixed, and 20% of the total mass of the composite probiotics and the composite reducing sugar preparation is added with water, and fermented at 37-45°C for 3d, and then fermented at 70-75°C for 3-5d to prepare a fermentation mixture. 4) After the metal ion complex and the fermentation mixture are uniformly mixed, an antiviral composition preparation D is prepared and stored at room temperature for standby use.

[0103] Application Example 1 Effects of different compositions on viral infection in infected animals

[0104] 1.1 Test materials

[0105] The alkaline mineral metal composition prepared in Example 1, purified water, and virus titers were all within the TCID 50 =10 4.2~4.6 Animal experiments were conducted on porcine deltacoronavirus virus liquid, porcine circovirus virus liquid, porcine rotavirus virus liquid, porcine respiratory and reproductive disorder virus virus liquid and pseudorabies virus virus liquid with a concentration of 100 μg / 0.1mL. The animal experiment was conducted at the Experimental Animal Center of Northeast Agricultural University in Heilongjiang Province from May 1 to May 15, 2023. The experimental period was 6 days. Newborn piglets were moved to the Experimental Animal Center of Northeast Agricultural University in Heilongjiang Province by a transfer vehicle after birth from a farm in Heilongjiang Province for 48 hours of adaptive feeding. They were grouped and treated on the 3rd day, and samples were taken on the 6th day. The sampling was carried out by the research group of Professor Li Jinlong of Northeast Agricultural University. Anal swabs, serum, intestinal slice samples and tissue samples of piglets were collected for subsequent testing. For details of the specific process, please see Figure 1 .

[0106] 1.2 Grouping

[0107] The experimental animals were 350 one-day-old newborn piglets weighing 1±0.1kg, divided into 14 treatments:

[0108] 1) Control group, denoted as C, was given normal drinking water and no other treatments;

[0109] 2) A drug administration group, denoted as A, wherein the alkaline mineral metal composition prepared in Example 1 was diluted 1000 times with water to obtain a water dilution of the alkaline mineral metal composition (wherein the concentration of the alkaline mineral metal composition was 100 mg / L), which was normally given to newborn piglets as drinking water, and the drinking amount of the water dilution for each piglet was 100 mL / kg / d, and no other treatment method was used;

[0110] 3) to 8), infection groups 1 to 6, denoted as S, R, D, P, O, and RR groups, were orally administered 1 mL of porcine epidemic diarrhea virus liquid, pseudorabies virus liquid, porcine deltacoronavirus virus liquid, porcine circovirus virus liquid, porcine rotavirus virus liquid, and porcine respiratory and reproductive disorder virus virus liquid, respectively, without other treatment methods;

[0111] 9) to 14), treatment groups 1 to 6 were respectively recorded as AS, AR, AD, AP, AO, and ARR groups. The alkaline mineral metal composition prepared in Example 1 was diluted 1000 times with water to obtain an alkaline mineral metal composition water dilution (wherein the concentration of the alkaline mineral metal composition was 100 mg / L), which was normally given to newborn piglets as drinking water. The drinking amount of the water dilution for each piglet was 100 mL / kg / d. At the same time, 1 mL of porcine epidemic diarrhea virus liquid, pseudorabies virus liquid, porcine deltacoronavirus virus liquid, porcine circovirus virus liquid, porcine rotavirus virus liquid, and porcine respiratory and reproductive disorder virus liquid were orally taken respectively;

[0112] Each group had 5 replicates and 5 animals in each replicate.

[0113] 1.3 Anal swab virus content detection

[0114] The anal swab obtained by sampling was immersed in virus preservation solution, and RT-qPCR was performed after the viral nucleic acid was extracted to evaluate the effect of the alkaline mineral metal composition on viral replication.

[0115] 1) RT-qPCR detection: The collected anal swabs were subjected to nucleic acid extraction using a DNA / RNA Co-extraction Kit (The DNA / RNA Co-extraction Kit, TIANGEN, DP422, China) and a reverse transcription kit (PrimeScript TM RTreagent Kit (Perfect Real Time, RR037A, TaKaRa, Japan) was used for RNA reverse transcription. Specific primers (see Table 1) and fluorescent dyes ( 480SYBR Green I Master, 04707516001, Roche, Switzerland) in QuantStudio TM 5Real-Time PCR detection system (Thermo, USA) was used for qPCR detection. The qPCR system and procedure were carried out according to the dye instructions.

[0116] Table 1 Specific primers for RT-qPCR detection of each virus

[0117]

[0118] 2) Virus content determination: A standard curve was established by cloning plasmids containing the corresponding viral genes (see Table 1) purchased from Seven Innovation Biotechnology Co., Ltd. (SEVEN, China). 1 Dilute ten-fold to 10 8The results (CT values) obtained by RT-qPCR after each dilution were used to establish standard curves for different viruses with the dilution multiple as the horizontal axis and the CT value as the vertical axis. The standard curve for porcine epidemic diarrhea virus is y=3.647x+6.146; the standard curve for porcine deltacoronavirus is y=4.564x-5.260; the standard curve for porcine circovirus is y=3.711x+1.953; the standard curve for porcine rotavirus is y=4.234x-3.461; the standard curve for porcine respiratory and reproductive disorder virus is y=4.147x+3.156; the standard curve for porcine pseudorabies virus is y=4.906x-1.230. The CT values ​​obtained by RT-qPCR detection of the test samples were used to obtain the corresponding virus content according to the standard curve.

[0119] Virus content test results Figure 2 As shown in Table 2, compared with group S, the content of porcine epidemic diarrhea virus in group AS was significantly (p≤0.0001) decreased; compared with group R, the content of porcine pseudorabies virus in group AR was significantly (p≤0.0001) decreased; compared with group D, the content of porcine deltacoronavirus in group AD was significantly (p≤0.001) decreased; compared with group P, the content of porcine circovirus in group AP was significantly (p≤0.001) decreased; compared with group O, the content of porcine rotavirus in group AO was significantly (p≤0.0001) decreased; compared with group RR, the content of porcine reproductive and respiratory syndrome virus in group ARR was significantly (p≤0.0001) decreased.

[0120] Table 2 Virus content detection results

[0121]

[0122]

[0123] The results show that the alkaline mineral metal composition of the present invention significantly inhibits the infection of porcine epidemic diarrhea virus, pseudorabies virus disease, porcine deltacoronavirus disease, porcine circovirus disease, porcine rotavirus disease and porcine respiratory and reproductive disease virus in the body.

[0124] Application Example 2 Effects of different compositions on gene levels and metabolic regulation in infected animals

[0125] The colon samples collected in Application Example 1 were rinsed with physiological saline to remove blood stains and dirt, and tissues not required for research were removed. Water stains were blotted off and cut into small pieces. The pieces were placed in a labeled 1.5 mL EP tube and quickly frozen in liquid nitrogen for subsequent experiments:

[0126] 2.1 Transcriptomics and metabolomics detection and analysis:

[0127] The experiment was conducted by Guangzhou Genedenovo Biotechnology Co., Ltd. (China) to evaluate the effect of the composition on the gene and metabolism regulation of newborn piglets. Figure 3 As shown in A: Compared with group C, group A had 442 differentially expressed genes, of which 164 were upregulated and 278 were downregulated; compared with group C, group S had 193 differentially expressed genes, of which 98 were upregulated and 95 were downregulated; compared with group C, group R had 508 differentially expressed genes, of which 258 were upregulated and 250 were downregulated; compared with group S, group AS had 1022 differentially expressed genes, of which 588 were upregulated and 434 were downregulated; compared with group R, group AR had 499 differentially expressed genes, of which 271 were upregulated and 228 were downregulated. The enrichment results of differentially expressed genes between group S and AS, and between group R and AR are shown in Figure 1. Figure 3 As shown in B, the differentially expressed genes mainly overlap in metabolic pathways, bile secretion and cholesterol metabolism. The effects of group C, group A, group S, group R, group AS and group AR on the metabolic expression levels of piglets are shown in Figure 3 As shown in C, compared with group C, group A had 76 differentially expressed metabolites; compared with group C, group S had 35 differentially expressed metabolites; compared with group C, group R had 55 differentially expressed metabolites; compared with group S, group AS had 78 differentially expressed metabolites; compared with group R, group AR had 69 differentially expressed metabolites. The classification results of differentially expressed metabolites between group S and group AS, group R and group AR are shown in Figure 3 As shown in D in FIG, the differential metabolites are mainly concentrated in organic acids and derivatives, lipids and lipid-like molecules, and heterocyclic compounds. From the above results, it can be seen that the alkaline mineral metal composition of the present invention significantly affects the lipid metabolism and ion homeostasis of piglets.

[0128] 2.2 Serum biochemical index detection:

[0129] The piglet serum collected in Application Example 1 was used as the test sample, and the cholesterol 7-α-hydroxylase detection kit (H461-1), total bilirubin detection kit (C019-1-1), total bile acid detection kit (E003-2-1), alkaline phosphatase detection kit (A059-2-2), phosphatidylinositol proteoglycan 3 detection kit (H455-1), triglyceride detection kit (A110-1-1) and total cholesterol detection kit (A111-1-1) were purchased from Nanjing Jiancheng Bioengineering Institute, China. The corresponding detection methods were carried out according to the manufacturer's instructions to evaluate the effect of the composition on lipid-related metabolites in newborn piglets. The test results of serum lipid-related biochemical indicators are as follows: Figure 4 As shown in Table 3, the results showed that compared with group C, triglyceride, glypican-3, total cholesterol and total bile acid in group S and group R were significantly (p≤0.05 or p≤0.0001) increased, and cholesterol 7α-hydroxylase and total bilirubin were significantly (p≤0.05 or p≤0.001) decreased; compared with group S and group R, triglyceride, glypican-3, total cholesterol and total bile acid in group AS and group AR were significantly (p≤0.01 or p≤0.0001) decreased, and cholesterol 7α-hydroxylase and total bilirubin were significantly (p≤0.01 or p≤0.0001) increased. From the above results, it can be seen that the alkaline mineral metal composition of the present invention significantly inhibits virus-mediated regulation of host lipid metabolism.

[0130] Table 3 Serum lipid-related biochemical index detection results

[0131]

[0132]

[0133] 2.3 Periodic acid Schiff staining, Oil red staining:

[0134] The colon samples collected in Application Example 1 were fixed in 4% paraformaldehyde (P0099, Beyotime, China) and glutaraldehyde (354400, Merck, USA) by volume, and then periodic acid Schiff staining and oil red staining were performed. Periodic acid Schiff staining and oil red staining were performed by Hangzhou Boerfu Biotechnology Co., Ltd. to evaluate changes in intestinal glucose and lipid metabolism. The results of periodic acid Schiff staining are shown in Figure 2. Figure 5As shown in A, the results showed that compared with group C, the glycogen content of group S decreased; compared with group S, the glycogen content of group AS increased; compared with group C, the glycogen content of groups R and AR did not change significantly. Figure 5 As shown in B, compared with group C, the lipids in the drug-treated group decreased; compared with group C, the lipids in groups S and R increased; compared with the lipids in groups S and R, the lipids in groups AS and AR decreased. It can be seen that the alkaline mineral metal composition of the present invention has universality in regulating virus-mediated lipid metabolism and is selective for virus-mediated sugar metabolism.

[0135] Application Example 3 Effects of different compositions on intestinal tissue morphology of infected animals

[0136] 3.1H&E staining:

[0137] The colon samples collected in Application Example 1 were fixed in 4% by volume paraformaldehyde (P0099, Beyotime, China) and glutaraldehyde (354400, Merck, USA) for H&E staining. The height of the villi, the depth of the crypts, the thickness of the submucosal layer, the thickness of the muscular layer, the thickness of the serosal layer and the density of the intestinal villi under scanning electron microscopy were used to evaluate the protective effect of the composition on the physical barrier of the intestinal tract of newborn piglets. The H&E staining was performed by Hangzhou Bolfu Biotechnology Co., Ltd. The results of H&E staining are shown in Figure 1. Figure 6 As shown in A, group C, group A, group S, group R, group AS and group AR had different effects on the intestinal tissue morphology of newborn piglets. The results showed that compared with group C, group A had better intestinal villus morphology and denser microvilli; compared with group S and group R, respectively, the intestinal villus morphology and U-shaped crypt damage in groups AS and AR were less severe.

[0138] 3.2 Scanning electron microscope detection:

[0139] The colon samples collected in Application Example 1 were fixed with glutaraldehyde at 4°C for 1.5h, rinsed three times with phosphate buffered saline (PBS) (BL302A, biosharp, China), dehydrated with 50%, 70%, 90% and 100% ethanol in sequence, and dehydrated twice with 100% ethanol for 10 minutes each time. Replaced with 50% and 100% tert-butanol in sequence, and replaced with 100% tert-butanol twice for 15 minutes each time. The sample was dried at -20°C overnight, pasted on the sample stage, and observed under an electron microscope after coating (S-3400N, HITACHI, Japan). The scanning electron microscopy results are shown in the figure. Figure 6As shown in Figure B, compared with group C, the intestinal villi of group S and group R had holes and the intestinal barrier was damaged; compared with group S and group R, the intestinal villi damage of group AS and group AR was reduced. It can be seen that the alkaline mineral metal composition of the present invention has a good protective effect on the intestinal barrier and helps the host resist the damage caused by viruses to the body.

[0140] Application Example 4 Effects of different compositions on viral replication and infection in animal cells infected with different viruses

[0141] 4.1 Test materials

[0142] The alkaline mineral metal composition prepared in Example 1, water, virus liquid (porcine epidemic diarrhea virus liquid, porcine delta coronavirus virus liquid, porcine circovirus virus liquid, porcine rotavirus virus liquid, porcine respiratory and reproductive disorder virus liquid, pseudorabies virus liquid and bovine viral diarrhea virus liquid), the virus titer in each virus liquid was within TCID 50 =10 4.2~4.6 / 0.1mL) and the antiviral composition preparation D prepared in comparative example 5 were subjected to cell tests. The cell test was carried out in the Key Laboratory of Pathogenesis and Comparative Medicine of Animal Diseases in Heilongjiang Province from September 1, 2022 to June 1, 2023. The test cells were porcine epidemic diarrhea virus susceptible cells, African green monkey kidney cells (Vero); porcine delta coronavirus and pseudorabies virus susceptible cells, porcine testicular cells (ST); porcine circovirus susceptible cells, porcine intestinal epithelial cells (IPEC-J2); porcine rotavirus susceptible cells, African green monkey embryonic kidney cells (MA104); porcine respiratory and reproductive disorder virus susceptible cells, African green monkey embryonic kidney cells (Marc145); bovine viral diarrhea virus susceptible cells, bovine kidney cells (MDBK). The test cell concentration was 1.8×10 6 ~2×10 6 The cell test cycle was 48 hours. After the test cells were revived from liquid nitrogen and passed to the stable generation, they were cultured in T25 cell bottles until the confluence was 80%. 5 0.25 μg of the alkaline mineral metal composition prepared in Example 1 or the same mass of the antiviral composition preparation D prepared in Comparative Example 5 was incubated for 24 hours, and the above-mentioned viruses were used to infect the above-mentioned corresponding susceptible cells respectively. After 24 hours, the supernatant samples and cell samples were collected for subsequent detection. The specific flow chart is shown in Figure 7 .

[0143] 4.2 Grouping

[0144] There were 189 bottles of T25 cells (3289, Corning, USA) in the above test cells, which were divided into 21 treatments:

[0145] 1) Infection group 1, denoted as M1, African green monkey kidney cells (Vero), water, infected with 0.1 mL porcine epidemic diarrhea virus solution, no other treatment;

[0146] 2) Infection group 2, denoted as M2, porcine testicular cells (ST), water, infected with 0.1 mL porcine deltacoronavirus solution, no other treatment;

[0147] 3) Infection group 3, denoted as M3, porcine intestinal epithelial cells (IPEC-J2), water, infected with 0.1 mL porcine circovirus solution, no other treatment;

[0148] 4) Infection group 4, denoted as M4, African green monkey embryonic kidney cells (MA104), water, infected with 0.1 mL porcine rotavirus solution, no other treatment;

[0149] 5) Infection group 5, denoted as M5, African green monkey embryonic kidney cells (Marc145), water, infected with 0.1 mL porcine respiratory and reproductive disorder virus solution, no other treatment;

[0150] 6) Infection group 6, denoted as M6, porcine intestinal epithelial cells (IPEC-J2), water, infected with 0.1 mL of porcine pseudorabies virus solution, no other treatment;

[0151] 7) Infection group 7, denoted as M7, bovine kidney cells (MDBK), water, infected with 0.1 mL of bovine viral diarrhea virus solution, no other treatment;

[0152] 8) Control group 1, denoted as C1, African green monkey kidney cells (Vero), antiviral composition preparation D prepared in comparative example 5, the dilution multiple of the antiviral composition preparation D prepared in comparative example 5 is 1.4*10 5 times, infected with 0.1 mL porcine epidemic diarrhea virus liquid, without other treatment;

[0153] 9) Control group 2, denoted as C2, porcine testicular cells (ST), infected with 0.1 mL porcine deltacoronavirus solution, and other treatments were the same as group C1;

[0154] 10) Control group 3, denoted as C3, porcine intestinal epithelial cells (IPEC-J2), infected with 0.1 mL porcine circovirus solution, and other treatments were the same as those of group C1;

[0155] 11) Control group 4, denoted as C4, African green monkey embryonic kidney cells (MA104), infected with 0.1 mL porcine rotavirus solution, and other treatments were the same as those of group C1;

[0156] 12) Control group 5, denoted as C5, African green monkey embryonic kidney cells (Marc145), infected with 0.1 mL porcine respiratory and reproductive disease virus solution, and other treatments were the same as group C1;

[0157] 13) Control group 6, denoted as C6, porcine intestinal epithelial cells (IPEC-J2), infected with 0.1 mL of porcine pseudorabies virus solution, and other treatments were the same as those of group C1;

[0158] 14) Control group 7, denoted as C7, bovine kidney cells (MDBK), infected with 0.1 mL of bovine viral diarrhea virus solution, and other treatments were the same as those of group C7;

[0159] 15) Experiment 1, denoted as A1, African green monkey kidney cells (Vero), containing the water dilution of the alkaline mineral metal composition prepared in Example 1, the dilution factor is 1.4*10 5 times, infected with 0.1mL porcine epidemic diarrhea virus liquid;

[0160] 16) Experimental group 2, denoted as A2, porcine testicular cells (ST), infected with 0.1 mL of porcine deltacoronavirus solution, and other treatments were the same as those of group A1;

[0161] 17) Experimental group 3, denoted as A3, porcine intestinal epithelial cells (IPEC-J2), infected with 0.1 mL porcine circovirus solution, and other treatments were the same as those of group A1;

[0162] 18) Experimental group 4, denoted as A4, African green monkey embryonic kidney cells (MA104), infected with 0.1 mL of porcine rotavirus solution, and other treatments were the same as those of group A1;

[0163] 19) Experimental group 5, denoted as A5, African green monkey embryonic kidney cells (Marc145), infected with 0.1 mL porcine respiratory and reproductive disorder virus solution, and other treatments were the same as those of group C1;

[0164] 20) Experiment 6, denoted as A6, porcine intestinal epithelial cells (IPEC-J2), infected with 0.1 mL of porcine pseudorabies virus solution, and other treatments were the same as those of group A1;

[0165] 21) Experimental group 7, denoted as A7, bovine kidney cells (MDBK), infected with 0.1 mL of bovine viral diarrhea virus solution, and other treatments were the same as those of group A7;

[0166] Each group had 3 replicates and 3 bottles in each replicate.

[0167] 4.3 RT-qPCR detection

[0168] The culture supernatant samples were pipetted with a pipette to obtain 0.5 mL of culture fluid from each group and placed in a labeled 1.5 mL EP tube. The nucleic acid was extracted to detect the viral gene transcription level for evaluating the effect of the composition on viral replication. The reagent method was consistent with that in Application Example 1.

[0169] The viral replication in each infection group, control group and experimental group is as follows Figure 8As shown in Table 4, compared with group M1, the replication rate of porcine epidemic diarrhea virus in group A1 was significantly (p≤0.01) decreased, while there was no significant change in group C1 (p>0.05); compared with group M2, the replication rate of porcine delta coronavirus in group A2 was significantly (p≤0.01) decreased, while that in group C2 was decreased (p≤0.05); compared with group M3, the replication rate of porcine circovirus in group A3 was extremely significantly (p≤0.001) decreased, while there was no significant change in group C3 (p>0.05); compared with group M4, the replication rate of porcine rotavirus in group A4 was significantly (p≤0.0 5) decreased, while there was no significant change in C4 group (p>0.05); compared with M5 group, the replication rate of porcine reproductive and respiratory virus in A5 group decreased extremely significantly (p≤0.0001), while it decreased significantly (p≤0.05) in C5 group; compared with M6 group, the replication rate of pseudorabies virus in A6 group decreased significantly (p≤0.01), while there was no significant change in C6 group (p>0.05); compared with M7 group, the replication rate of bovine viral diarrhea virus in A7 group decreased extremely significantly (p≤0.0001), while it decreased significantly (p≤0.001) in C7 group.

[0170] Table 4 Virus replication

[0171]

[0172] It can be seen that the alkaline mineral metal composition of the present invention significantly inhibits the virus replication efficiency and is superior to the antiviral composition preparation D prepared in Comparative Example 5.

[0173] 4.4 Immunofluorescence detection

[0174] After the cell slide was washed with phosphate buffer, it was fixed in 4% paraformaldehyde solution for 10 minutes, permeabilized with TritonX-100 (A16046, Thermo Fisher Scientific, USA) for 10 minutes, blocked with 3% bovine serum albumin (BSA, BS114, Biosharp, China) for 1 hour, incubated with mouse-derived porcine epidemic diarrhea virus antibody (SD17-103, Medgene Labs, USA) or porcine delta coronavirus antibody (SD55-197, Medgene Labs, USA) or porcine circovirus antibody (made by the key technology innovation team for livestock and poultry disease prevention and control of Northeast Agricultural University) or porcine pseudorabies virus antibody (donated by Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences) for 1 hour, and incubated in the dark for 30 minutes with Alexa Fluor 488-labeled goat anti-mouse IgG (A0428, Beyotime, China). Observation was performed using a fluorescence microscope (THUNDER, Leica, Germany) to evaluate the effect of the composition on intracellular viral infection.

[0175] The viral infection in cells of each infection group and experimental group is shown in Fig. 9 As shown, compared with the M1 group, the porcine epidemic diarrhea virus infection in the A1 group decreased; compared with the M2 group, the porcine delta coronavirus infection in the A2 group decreased; compared with the M3 group, the porcine circovirus infection in the A3 group decreased; compared with the M6 ​​group, the pseudorabies virus infection in the A6 group decreased. This shows that the alkaline mineral metal composition of the present invention can inhibit virus infection in cells.

[0176] Application Example 5 Effects of different compositions on lipid content in animal cells infected with different viruses

[0177] The lipid content in animal cells infected with different viruses was detected by lipid droplet red fluorescence detection. The cell samples were taken out from T25 cell bottles with cell slides (BS-14-RC, biosharp, China), washed with phosphate buffered saline (PBS), and stained with a lipid droplet red fluorescence detection kit (Lipid Droplets Red Fluorescence Assay Kit with Nile Red, C2051M, Beyotime, China) to evaluate the effect of the composition on intracellular lipids. The intracellular lipid content of each infection group and test group is shown in Figure 2. Fig.10 As shown, compared with the M1 group, the lipid content of the A1 group decreased; compared with the M2 group, the lipid content of the A2 group decreased; compared with the M3 group, the lipid content of the A3 group decreased; compared with the M6 ​​group, the lipid content of the A6 group decreased. It can be seen that the alkaline mineral composition of the present invention significantly inhibits the host lipid metabolism controlled by the virus and reduces the fat content.

[0178] Application Example 6 Effects of different compositions on bacterial reproduction efficiency

[0179] 6.1 Test materials

[0180] The alkaline mineral metal composition prepared in Example 1 was subjected to an antibacterial test. The antibacterial test was conducted in the Key Laboratory of Animal Disease Pathogenesis and Comparative Medicine of Heilongjiang Province from July 1, 2022 to September 1, 2022. The test bacteria included Streptococcus suis and Escherichia coli, and the bacterial density was OD = 1.0. Each bacteria was tested for 10 8 10 mL shaking tube, LB medium (10855001, Thermo, USA).

[0181] 6.2 Grouping

[0182] 6.2.1 Grouping of Streptococcus suis detection test

[0183] There are 12 treatment groups:

[0184] 1) Negative control group, denoted as NC, LB medium, no other treatment;

[0185] 2) Treatment group 1, recorded as 1:200, LB medium, 5 mg of the alkaline mineral metal composition prepared in Example 1 was diluted with 200 times the mass (1 mL) of water, the dilution multiple was 1:200, and simultaneously infected with 0.1 mL of Streptococcus suis, without other treatments;

[0186] 3) to 11), respectively, treatment groups 2 to 10, recorded as 1:225, 1:250, 1:300, 1:400, 1:500, 1:750, 1:1000, 1:2000, respectively, and the only difference from treatment group 1 is that the dilution multiples of the composition are 225, 250, 300, 350, 400, 500, 750, 1000 and 2000 times, respectively;

[0187] 12) Positive control group, denoted as PC, using LB medium (10855001, Thermo, USA) to prepare bacterial solution, the bacterial solution includes one of the Streptococcus suis, and the bacterial density is OD = 1.0;

[0188] Each group had 3 replicates and 3 tubes in parallel.

[0189] 6.2.2 E. coli detection test grouping

[0190] There are 12 treatment groups:

[0191] They are groups 13) to 24) respectively, and the treatment methods of each group correspond to groups 1) to 12) in 6.2.1 of the Streptococcus suis detection test grouping, with the only difference being that Streptococcus suis is replaced by Escherichia coli.

[0192] 6.3 Bacteria density detection

[0193] The test cycle is 12 hours. After the test bacteria are revived and activated in the ultra-low temperature refrigerator, a bacterial solution is obtained. 5 mg of the alkaline mineral metal composition prepared in Example 1 and 0.1 mL of Streptococcus suis or Escherichia coli diluted to a corresponding multiple are added to 10 mL of LB medium. After 12 hours, bacterial solution samples are collected for subsequent testing. 2 μL of each group of bacterial solution samples is taken with a pipette and placed in a calibrated ultraviolet spectrophotometer for bacterial density detection to evaluate the effect of the inhibitor on bacterial reproduction.

[0194] The bacterial growth in the control group and treatment group is shown in Fig.11As shown in Table 5, compared with the positive control group, the density of Streptococcus suis in the 1:200-1:500 group was significantly decreased (p≤0.0001); compared with the positive control group, the density of Escherichia coli in the 1:200-1:1000 group was significantly decreased (p≤0.0001). It can be seen that the alkaline mineral metal composition of the present invention significantly inhibits the bacterial reproduction efficiency.

[0195] Table 5 Bacterial reproduction

[0196] Grouping NC 1:200 1:225 1:250 1:300 1:350 1:400 1:500 1:750 1:1000 1:2000 PC Escherichia coli (OD) 0.045 0.110 0.088 0.159 0.281 0.524 0.758 0.646 0.715 0.915 1.107 1.234 Streptococcus suis (OD) 0.030 0.064 0.054 0.024 0.082 0.067 0.082 0.063 1.083 1.079 1.096 1.106

[0197] Application Example 7: Synergistic Effect Verification Test

[0198] 7.1 Test materials

[0199] The alkaline mineral metal composition A prepared in Example 1, the alkaline mineral metal composition B prepared in Example 2, the alkaline mineral metal composition C prepared in Example 3, the metal ion complex single component substance A1 prepared in Comparative Example 1, the alkaline mineral complex single component substance A2 prepared in Comparative Example 2, the alkaline rare earth soluble salt single component substance A3 prepared in Comparative Example 3, and the composite gel single component substance A4 prepared in Comparative Example 4 were diluted with water (0.25 μL, wherein the mass ratio of each substance to water is 1:1.4*10 5 ), virus fluid (porcine epidemic diarrhea virus fluid, porcine deltacoronavirus virus fluid, porcine circovirus virus fluid, porcine rotavirus virus fluid, porcine respiratory and reproductive disorder virus virus fluid and pseudorabies virus virus fluid, the virus titer is all in TCID 50 =10 4.2~4.6 The composition test was conducted in the Key Laboratory of Animal Disease Pathogenesis and Comparative Medicine of Heilongjiang Province from April 1, 2022 to May 1, 2022. The test cells were African green monkey kidney cells (Vero), and the test cell concentration was 2×10 6 Pieces / mL.

[0200] 7.2 Grouping

[0201] A total of 54 bottles of T25 cells were divided into 6 treatments:

[0202] 1) Positive control group, denoted as PC, African green monkey kidney cells (Vero), infected with 0.1 mL porcine epidemic diarrhea virus (PEDV), without other treatment;

[0203] 2) Metal ion complex single component substance A1 group, denoted as A1, was added with water dilution of metal ion complex single component substance A1, and other treatments were the same as those of PC group;

[0204] 3) Alkaline mineral complex single component substance A2 group, denoted as A2, added with water dilution of metal alkaline mineral complex single component substance A2, and other treatments were the same as those of group A1;

[0205] 4) Alkaline rare earth soluble salt single component substance A3 group, denoted as A3, added with water dilution of alkaline rare earth soluble salt single component substance A3, and other treatments were the same as those of group A1;

[0206] 5) Composite gel single component substance A4 group, denoted as A4, was added with water dilution of composite gel single component substance A4, and other treatments were the same as those of group A1;

[0207] 6) Alkaline mineral metal composition group, denoted as A, to which the water dilution of the alkaline mineral metal composition in Example 1 was added, and other treatments were the same as those of group A1;

[0208] 7) Alkaline mineral metal composition group, denoted as B, to which the water dilution of the alkaline mineral metal composition in Example 2 was added, and other treatments were the same as those of group A1;

[0209] 8) The alkaline mineral metal composition group, denoted as C, was added with the water dilution of the alkaline mineral metal composition in Example 3, and the other treatments were the same as those of Group A1.

[0210] Each group had 3 replicates and 3 bottles in each replicate.

[0211] 7.3 Viral gene transcription level detection

[0212] The test cycle is 48 hours. After the test cells are revived from liquid nitrogen and passed to the stable generation, they are cultured in a T25 cell flask until the confluence is 80%. The above components are added and incubated for 24 hours. After 24 hours, the supernatant samples are collected for subsequent testing. The supernatant samples are pipetted with a pipette to obtain 0.5 mL of the culture fluid from each group and placed in a labeled 1.5 mL EP tube. The nucleic acid is extracted to detect the level of viral gene transcription. The RT-qPCR reagent method is consistent with that in Application Example 1 and is used to evaluate the effects of different components on viral replication. The viral replication of each group is shown in Figure 2. Fig.12As shown in Table 6, compared with the PC group, the porcine epidemic diarrhea virus content in group A1 decreased significantly (p≤0.01), the porcine epidemic diarrhea virus content in group A2 decreased extremely significantly (p≤0.001), the porcine epidemic diarrhea virus content in group A3 decreased extremely significantly (p≤0.001), and the porcine epidemic diarrhea virus content in group A4 did not change significantly (p>0.05). The porcine epidemic diarrhea virus content in group A decreased extremely significantly (p≤0.0001), and the porcine epidemic diarrhea virus content in groups B and C decreased extremely significantly (p≤0.001). In addition, compared with group A2, which had the best single-component effect, the porcine epidemic diarrhea virus content in groups A, B and C decreased significantly (p≤0.01). Moreover, compared with group B or group C, the porcine epidemic diarrhea virus content in group A decreased significantly (p≤0.01).

[0213] Table 6 Virus replication

[0214]

[0215] It can be seen that the four components in the alkaline mineral metal composition for antiviral use of the present invention have a synergistic effect, and the effect of the combination is greater than the effect of each component used alone.

[0216] In summary, the combination of the present invention can regulate the body's lipid metabolism, inhibit viral replication and transmission, and enhance the intestinal barrier. The alkaline mineral metal composition can effectively inhibit piglet viral infection. Moreover, the metal ion complex in the alkaline mineral metal composition of the present invention can maintain the body's water balance, maintain energy metabolism, and will not produce toxic side effects and drug resistance. Since the digestive system and immune system of piglets are not yet fully developed, supplementing mineral complexes can improve the body's antioxidant effect and promote immune system function. And mineral complexes can regulate metabolism and physical development, improve intestinal morphology, and reduce cholesterol. The alkaline rare earth in the alkaline mineral metal composition can promote blood circulation and play a role in filtering toxins. In addition, by using composite gel as the base of the alkaline mineral metal composition, the intestinal barrier can be consolidated, the proliferation of harmful bacteria can be inhibited, and it is easy to store. Therefore, it can be used as a vaccine substitute for antiviral.

[0217] Although the above embodiment describes the present invention in detail, it is only a part of the embodiments of the present invention, not all of the embodiments. People can also obtain other embodiments based on this embodiment without creativity, and these embodiments all fall within the protection scope of the present invention.

Claims

1. An alkaline mineral metal composition, characterized in that: The invention comprises the following components in parts by weight: 60 to 70 parts of metal ion complex, 25 to 30 parts of mineral ion complex, 1 to 9.5 parts of alkaline rare earth soluble salt and 0.5 to 4 parts of composite gel.

2. The alkaline mineral metal composition according to claim 1, characterized in that The metal ion complex comprises a sodium compound, a potassium compound, a zinc compound and an iron compound; the mass ratio of sodium ions, potassium ions, zinc ions and iron ions in the sodium compound, potassium compound, zinc compound and iron compound is (16.48-19.02): (41.21-43.18): (0.23-0.25): (2.06-7.93); the sodium compound comprises one or more of sodium chloride, sodium carbonate, sodium selenate and sodium metasilicate; the potassium compound comprises one or more of potassium chloride, potassium iodide and potassium carbonate; the zinc compound comprises zinc gluconate; the iron compound comprises one or more of ferrous sulfate, ferrous lactate and ferrous gluconate.

3. The alkaline mineral metal composition according to claim 1, characterized in that: The mineral ion complex includes selenium compounds, iodine compounds and silicon compounds; the mass ratio of selenium ions, iodine ions and silicon ions in the selenium compounds, iodine compounds and silicon compounds is (1.14-4.67): (18.66-25): (1.14-4.67); the selenium compound includes sodium selenate; the iodine compound includes potassium iodide; and the silicon compound includes sodium metasilicate.

4. The alkaline mineral metal composition according to claim 1, characterized in that The alkaline rare earth soluble salt comprises digermanate and lanthanum carbonate; the mass ratio of the digermanate to lanthanum carbonate is (0.87-3.8): (0.13-5.7).

5. The alkaline mineral metal composition according to claim 1, characterized in that: The composite gel comprises sodium alginate and nano silver; the mass ratio of the sodium alginate to the nano silver is (0.48-3): (0.02-1).

6. The method for preparing the alkaline mineral metal composition according to any one of claims 1 to 5, characterized in that: The following steps are involved: The metal ion complex, the mineral ion complex and the alkaline rare earth soluble salt are sequentially dissolved in the composite gel and ionized to obtain an alkaline mineral metal composite.

7. The preparation method according to claim 6, characterized in that: The ionization temperature is 25 to 35° C.; the ionization potential is -25 to 25 mV; and the ionization time is 1 to 2 days.

8. An antiviral preparation, characterized in that The invention comprises the alkaline mineral metal composition according to any one of claims 1 to 5 or the alkaline mineral metal composition prepared by the preparation method according to claim 6 or 7.

9. Use of the alkaline mineral metal composition according to any one of claims 1 to 5, the alkaline mineral metal composition prepared by the preparation method according to claim 6 or 7, or the antiviral preparation according to claim 8 or 9 in the preparation of drugs for preventing and / or treating viral infections in livestock.

10. The use according to claim 9, characterized in that: The virus includes one or more of a coronavirus, a circovirus, a rotavirus, an arterivirus and a herpesvirus.